Commentary
Researchers associated with a prestigious teaching hospital released a sensationalistic and highly suspect study aimed at supporting Congressional legislation. The study, launched with an op-ed in the New York Times, points fingers at an evil, nebulous industry, yet forgets to note the researchers’ own role in exacerbating problems of drug affordability.